PIASx Antibodies

Santa Cruz Biotechnology offers a broad range of PIASx monoclonal antibodies for investigating PIASx in cellular processes. PIASx monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PIASx, or Protein Inhibitor of Activated STATx, regulates the STAT signaling pathway, which mediates cellular responses to cytokines and growth factors. Through modulation of STAT proteins, PIASx influences immune response, cell proliferation, and differentiation. Understanding PIASx function is essential for research into cancer and autoimmune disorders. PIASx monoclonal antibodies enable detailed examination of protein expression patterns and interactions within cellular pathways. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates provide versatile options for visualization and quantification. PIASx monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge of cellular signaling mechanisms and disease pathways.